Worldwide Total Prescription and oTC Pharma Sales by Therapy Area
It’s little surprise that the major growth area here is oncology, where much of the R&D is going and much of the
return is expected. Systemic anti-infectives, central nervous system medications and anti-diabetics also look like
they will experience an upswing, while cardiovascular products may experience a modest comeback after several
years of decline.